BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42,267 | -2.7% | 54,000 | -8.5% | 0.00% | – |
| Q1 2023 | $43,424 | -100.0% | 59,000 | -99.6% | 0.00% | -100.0% |
| Q2 2022 | $8,157,000,000 | -24.6% | 15,000,000 | -20.5% | 0.01% | -13.3% |
| Q1 2022 | $10,823,918,000 | +528.2% | 18,857,000 | +701.4% | 0.02% | +650.0% |
| Q4 2021 | $1,722,890,000 | -93.3% | 2,353,000 | -85.1% | 0.00% | -94.1% |
| Q2 2021 | $25,820,160,000 | +59.7% | 15,744,000 | +60.6% | 0.03% | +41.7% |
| Q1 2021 | $16,170,718,000 | – | 9,804,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 128,338,000 | $101,094,132 | 3.30% |
| Affinity Asset Advisors, LLC | 12,000,000 | $9,452,614 | 3.30% |
| ARISTEIA CAPITAL, L.L.C. | 157,723,000 | $124,241,221 | 2.76% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $6,653,102 | 1.79% |
| TFG Asset Management GP Ltd | 10,000,000 | $7,848,611 | 1.06% |
| 683 Capital Management, LLC | 12,250,000 | $9,608,655 | 0.69% |
| Context Capital Management, LLC | 8,785 | $6,920 | 0.63% |
| Weiss Asset Management LP | 10,000,000 | $7,814,740 | 0.60% |
| MACKAY SHIELDS LLC | 14,404,000 | $11,346,287 | 0.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7,500,000 | $5,882,850 | 0.26% |